MTT assay results demonstrated that si-HULC can inhibit the expression of HULC to decrease HCC cell viability; however, when pretreated with the miR-3200-5p inhibitor, cell viability is increased in HCC cells (Figure 5(b)). Here, HULC is linked to hepatocellular carcinoma.